The Challenge and Excitement of Discovering New Medicines
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Dr Nigel Bennee.
At AstraZeneca, our purpose is to push the boundaries of science to deliver life-changing medicines. The future treatment for many of today’s diseases lies in discovering new biology, and understanding and challenging scientific hypotheses, to develop novel therapies. The advent of the genomics revolution brings with it an expanding list of pathways and targets to pursue – and with it new drug discovery challenges. By combining new technologies with medical understanding, we are making progress in our ability to define and deliver novel treatments for a variety of complex diseases. We also recognise that to be successful we need to work in partnership. Our teams continue to find innovative ways of collaborating with the best academic and industrial partners.
This talk is part of the Cambridge Society for the Application of Research (CSAR) series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|
![[Search]](http://talks.cam.ac.uk/images/search.gif?1209136071)
|![[A-Z Index]](http://talks.cam.ac.uk/images/az.gif?1209136071)
|![[Contact]](http://talks.cam.ac.uk/images/contact.gif?1209136071)
![[University of Cambridge]](http://talks.cam.ac.uk/images/identifier2.gif?1209136071){kind=small}
![[Talks.cam]](http://talks.cam.ac.uk/images/talkslogosmall.gif?1209136071)
Dr Menelas Pangalos, Executive Vice-President, Astra Zeneca
Monday 18 January 2016, 19:30-21:00